Feeds:
Posts
Comments

Posts Tagged ‘Astellas’

Here is a listing of recent pharma/device/biotech job openings in training, for those who are interested:

Manager, Sales Training and Development, Sunovion, MA

Sales Training Manager – Oncology, EMD Serono, MA

Manager/Associate Director, Oncology Clinical Training & Development, Novartis, NJ

Manager/Associate Director, Sales Training (Oncology), Novartis, NJ

Sales Training Manager, Shionogi, NJ

Hospital & Specialty Sales Trainer, Daiichi-Sankyo, NJ

National Sales Trainer, Daiichi-Sankyo, NJ

Director, Talent Management, Daiichi-Sankyo, NJ

Senior Manager, Leadership Development, Daiichi-Sankyo, NJ

Manager, Medical Device Training and Communications, Ikaria, NJ

Sales Training Manager – Oncology, Astellas, IL

Sr. Manager, Training & Communication (Compliance), Abbott, IL

Manager of Sales Training, Vivus, CA

Manager/Sr. Manager, Learning Technologies, Roche/Genentech, CA

Note: Impactiviti has no connection to the hiring personnel in these companies. The links are posted strictly as a service. Apply directly to the companies according to directions given on their individual job postings.

_________

Impactiviti is the Pharmaceutical Connection Agency. As the eHarmony of sales/training/marketing, we help our pharma/biotech clients find optimal outsource vendors through our unique trusted referral network. Need something? Ask Steve.

Learn more about us here.

 

Read Full Post »

Welcome back! First, a couple of links of interest to kick off the new year:

:: Are Walnuts now Drugs? Ask the FDA! (Nanny state alert)

:: Made-up Disease (YouTube)

UPDATE: Some more jobs that have been posted in the past week or so, in addition to the original list!

Director, Global Training and Development, Customer Management, J&J (NJ)

Sales Trainer, Stryker, NJ

Manager, Sales Training and Development, Eisai (NJ)

Manager, Sales Training, Aptalis (NJ)

Director/Sr Director, Commercial Training and Development, Regeneron (NY)

Dir, Global Sales Training and Development, Alexion (CT)

Sales Training and Program MgrBecton, Dickinson (Baltimore)

Assistant Skills Development, Sales and Marketing Director, Astellas (Chicago)

Dir, Sr Global Quality and Compliance Training, Allergan (CA)

It’s been a rough year for trainers, but it seems like the job opening spigot is beginning to open as we approach the end of 2011.

Here’s a list of some fresh opening for you to explore (Impactiviti has no further information or “inside track” on these listings – they’re posted here as a service to the Impactiviti network):

Training Manager, Specialty Products, Eisai (NJ)

Sales Training Specialist, Otsuka (NJ)

Associate Sales Training Director, Shire (PA)

Associate Director, Managed Markets Training, B-I (CT)

Assistant Director, Oncology Sales Training, Astellas (Chicago)

Corporate Medical Sales Trainer, Recruiter (Chicago)

National Sales Training Manager, Allergan (CA)

Director, Sales Training and Development, Somaxon (CA)

Brand Trainer, Genentech (CA)

Sales Training Consultant, Avanir (CA)

_________

Impactiviti is the Pharmaceutical Connection Agency. As the eHarmony of sales/training/marketing, we help our pharma/biotech clients find optimal outsource vendors for training, eMarketing, social media, and more.

Learn more about us here.

_________

Sign up for the Impactiviti Connection semi-weekly e-newsletter (see sample), chock full of news and resources for pharmaceutical professionals

Read Full Post »

*****

TODAY’S NEWS

WebMD makes some changes to rigged depression test. This kind of thing is just stupid. Come on, people.

Astellas looking to buy OSI. Smart pharma companies are looking up to gain a strong oncology franchise.

Shire gets approval for its Gaucher drug.

AstraZeneca buying out Merck‘s interest in certain jointly-marketed products.

RECOMMENDED

Executive Leadership – Yes, even the top echelon folks need coaching and training to continue their development. We’ve got the providers you need in the Impactiviti network. Contact us (stevew at impactiviti dot com, or phone at 973-947-7429) for recommendations.

PLUS

Some new primary-care doctors are going for a cash-only practice (from KevinMD). Can hardly blame them – soon all the government/regulatory/insurance nonsense will bring back the barter system!

JUST FOR FUN

———-

Subscribe to the Impactiviti blog via e-mail (which will bring you Impactiviti Daily – a brief of the day’s top pharma news)

Visit the Impactiviti Job Board

Sign up for the Impactiviti Connection twice-monthly e-newsletter (see sample)

*****

Read Full Post »

Where I’ll be next week: Sept. 23-24 – MedAdNews PharmaMed Marketing and Media conference, Princeton, NJ. I’ll be speaking on social media opportunities in pharma, and live-blogging.

TODAY’S NEWS

Novartis sees positive results with experimental COPD drug – Swiss drugmaker Novartis said a respiratory medicine improved lung function and significantly reduced breathlessness in a late stage trial. The outcome added to data suggesting QAB149 will challenge blockbusters like Pfizer’s Spiriva and GlaxoSmithKline‘s Advair, giving Novartis an edge in one of the industry’s most lucrative therapeutic areasmore

J&J/Elan deal getting the once-over to try to appease Biogen Elan, the Irish domiciled biotech company, will receive $115m less than previously agreed from Johnson & Johnson as part of a revised investment deal designed to salvage a pivotal partnership with Biogen Idecmore

Eli Lilly to do massive re-org – Eli Lilly announced that it would eliminate approximately 5,500 positions as part of a massive reorganization strategy that’s expected to net the firm reduce $1 billion in costs by 2011. This move will drop the company’s headcount from approximately 40,500 to 35,000. The company hasn’t revealed where the cuts will come from or how many will be real layoffs and how many will simply be reduced positionsmore More from the Lilly CEO here.

New MRSA drug approved – Theravance Inc. and partner Astellas Pharma won FDA approval for their superbug-fighting drug telavancin, which will bring the South San Francisco company a $20 million milestone paymentmore

GSK will have to share Paxil e-mails in birth defect lawsuit.

An interesting analysis of Qnexa (the next weight-loss drug?) by Jim Edwards. Is it too good??

Metformin as a treatment for cancer??

RECOMMENDED

Change. Innovation. Do you need to provide training to your team on change management? Or bringing about effective innovation? The Impactiviti Partner network has great vendor/partners who can help you with these offerings. Contact us (stevew at impactiviti dot com, or phone at 973-947-7429) for information and recommendations!

PLUS

A new site for accessing medical device/pharmaceutical sales positions listed by recruiters: MedPharmReps.

JUST FOR FUN

Do you know anyone with their internal organs reversed? Turns out that there are such folks…maybe even you!

We had a wonderful and restful vacation last week, touring through Massachusetts, Maine, New Hampshire, and Vermont. I uploaded some pictures along the way on my “twitpic” account – here’s one sample:

VermontWine

———-

Subscribe to the Impactiviti blog via e-mail

Connect with Steve Woodruff

Read Full Post »

The Skinny on Diabetes Drugs – a helpful little summary on current treatments from the Motley Fool.

Beaker’s Blog tells us that only 4 life sciences companies really matter. Who are they, and why?

Astellas continues to pursue CV Therapeutics after takeover bid rejected.

——

Subscribe to the Impactiviti blog via e-mail

Subscribe to the Impactiviti blog via RSS

Connect with Steve Woodruff

Read Full Post »